Intracranial Pressure Monitoring Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Technique (Invasive, Noninvasive), By Application (Traumatic brain injury, Meningitis, Intracerebral hemorrhage, Others (CNS infection, cerebral edema), and Region Forecast 2020-2031                

Intracranial Pressure Monitoring Devices Market size was valued at US$ 1.8 billion in 2024 and is expected to reach US$ 2.9 billion by 2031, growing at a significant CAGR of 6.8% from 2025-2031. Intracranial pressure monitoring (ICP) is a diagnostic procedure that assists doctors in determining if high or low cerebrospinal fluid (CSF) pressure is causing symptoms. The pressure in the head is measured directly using a tiny pressure-sensitive probe introduced through the skull. ICP is calculated in two methods. A short, hollow tube (catheter) is inserted into the fluid-filled area in the brain (ventricle), or an open device (bolt) is inserted through the skull into the region immediately between the skull and the brain. The growing frequency of neurological illnesses and severe accidents are pushing the intracranial pressure monitor market. The invasive techniques segment is anticipated to grow at a significant CAGR over the forecast years owing to invasive ICP measurements may be conducted at a variety of intracranial anatomical regions (i.e., intraventricular, intraparenchymal, epidural, subdural, and subarachnoidal). Furthermore, an cryoablation catheter connected to an external pressure transducer is the gold standard for continuous ICP monitoring, according to the Department of Clinical Neurosciences.

This approach has been proven to be the most accurate and low-cost way for ICP monitoring, and it may also be utilized for therapeutic CSF draining and medication delivery. External ventricular drain and micro-transducer ICP monitoring are the two types of invasive procedures now in use. The market is seeing increased product demand for a variety of reasons. One of the primary reasons driving the growth of the market is the increasing number of road traffic injuries and associated trauma cases, the rising number of individuals suffering from traumatic brain injury (TBI), increasing prevalence of autoimmune, cardiovascular, and sleep disorders has catalysed the demand for ICT monitors to provide early and effective treatment.

Key Developments

In May 2019, The FDA has issued a class I recall for Integra LifeSciences LimiTorr Volume Limiting Cerebrospinal Fluid (CSF) Drainage System and its MoniTorr Intracranial Pressure (ICP) External CSF Drainage and Monitoring Systems.